Overview
Employees
11-50
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 14, 2020 | Juvabis causes a stir with new antibiotic | A single intravenous dose Phase 1 study in healthy volunteers showed that Juvabis’ EBL-1003 (apramycin) was safe and well tolerated in all dose groups. The results support further clinical development of EBL-1003 in patients. |
Reviews 0
FAQ about Juvabis’
What has the press written about Juvabis’?
Parsers VC has collected 2 articles mentioning Juvabis’, among them “Juvabis causes a stir with new antibiotic” (Dec 14, 2020).
Is Juvabis’ still active?
Yes, Juvabis’ is active; its latest activity on Parsers VC dates from Dec 14, 2020.